Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

ClinicalTrials.gov ID: NCT05543707

Public ClinicalTrials.gov record NCT05543707. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 10:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Double-blind, Randomized Study to Evaluate the Antiviral Activity, Safety, and Efficacy of Orally Administered PBI-0451(Pomotrelvir) Compared With Placebo in Nonhospitalized Symptomatic Adults With COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI-0451(Pomotrelvir) is a new chemical entity and inhibitor of the main protease of coronaviruses, including the SARS-CoV-2 that causes COVID-19 disease. This study is designed to evaluate the antiviral activity, safety, and efficacy of orally administered PBI-0451(Pomotrelvir) compared with placebo.

Study identification

NCT ID
NCT05543707
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pardes Biosciences, Inc.
Industry
Enrollment
242 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2022 (Actual)
Primary completion
Jan 27, 2023 (Actual)
Completion
Apr 14, 2023 (Actual)
Last update posted
Dec 11, 2024

2022 – 2023

United States locations

U.S. sites
54
U.S. states
15
U.S. cities
44
Facility City State ZIP Site status
Voyage Medical Mesa Arizona 85210 —
Franco A Felizarta MD Bakersfield California 93301-1692 —
Hope Clinical Research, LLC Canoga Park California 91303 —
Biopharma Informatic, LLC Encino California 91436 —
Ascada Research LLC Fullerton California 92835-3424 —
Ark Clinical Research - Long Beach - Clinedge - PPDS Long Beach California 92868 —
Valiance Clinical Research Tarzana California 91356-6695 —
Allianz Research Institute - Colorado Westminster California 92683-4454 —
TrueBlue Clinical Research- Brandon - HyperCore - PPDS Brandon Florida 33511-4850 —
Beautiful Minds Clinical Research Center Cutler Bay Florida 33157 —
Indago Research and Health Center Hialeah Florida 33012-4174 —
Quality Research of South Florida Hialeah Florida 33016-1811 —
Gonzalez M.D. & Aswad M.D. Health Care Services Miami Florida 33125 —
Universal Medical and Research Center, LLC Miami Florida 33126 —
CCM Clinical Research Group Miami Florida 33133-4231 —
D&H National Research Centers Miami Florida 33155-3262 —
Allied Biomedical Research Institute Miami Florida 33155-4630 —
Florida International Medical Research Miami Florida 33155 —
P&S Research, LLC Miami Florida 33175 —
The Angel Medical Research Corporation Miami Lakes Florida 33016-1641 —
South Florida Research Miami Springs Florida 33166 —
EMINAT Research Miramar Florida 33027 —
Combined Research Orlando Phase I-IV LLC Orlando Florida 32803 —
Ormond Beach Clinical Research Ormond Beach Florida 32174 —
CTMD Research, Inc. - Palm Springs - Hunt - PPDS Palm Springs Florida 33406 —
IMIC Inc. Palmetto Bay Florida 33157-5503 —
Infectious Disease Consultants of the Treasure Coast Sebastian Florida 32958 —
Westchester General Hospital South Miami Florida 33143-5045 —
DBC Research Tamarac Florida 33321 —
Alliance Clinical Research-(Tampa) Tampa Florida 33615-3816 —
Palm Beach Research - ClinEdge - PPDS West Palm Beach Florida 33409 —
Agile Clinical Research Trials, LLC Atlanta Georgia 30328 —
Centricity Research - Roswell - HyperCore - PPDS Columbus Georgia 31904 —
Eagle Clinical Research Chicago Illinois 60621-3116 —
Revival Research Corporation - Clinedge - PPDS Sterling Heights Michigan 48312 —
Safe Haven Clinical Research Clinton Mississippi 39056-5606 —
Mercury Street Medical Group Butte Montana 59701-1652 —
Las Vegas Medical Research Las Vegas Nevada 89128-0373 —
Research Carolina Elite Denver North Carolina 28037-7929 —
WellNow Urgent Care Troy Urgent Care Dayton Ohio 45424 —
STAT Research Vandalia Ohio 45377 —
Clinovacare Medical Clinical Research Center West Columbia South Carolina 29169 —
Veritas Health Care Group West Columbia South Carolina 29169 —
Clinical Trials Center of Middle Tennessee Franklin Tennessee 37067-5663 —
Central Texas Clinical Research Austin Texas 78705 —
Zenos Clinical Research Dallas Texas 75230-6895 —
Proactive Clinical Research, LLC Edinburg Edinburg Texas 78539-4660 —
Care United Research, LLC Forney Texas 75126-4174 —
Mercy Family Clinic Houston Texas 75211 —
Xpress Trials Houston Texas 77036-8280 —
Diversified Medical Practices, P.A. Houston Texas 77084 —
Epic Clinical Research Lewisville Texas 75057 —
VIP Trials San Antonio Texas 78230 —
Suffolk Multispecialty Research Suffolk Virginia 23435-3762 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05543707, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2024 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05543707 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →